Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130265002M |
| Application |
Infection |
The kit has been designed for the qualitative determination of EBV EA IgA in human serum. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
Efficient EBV DetectionThe MAGLUMI EBV EA IgA kit is engineered for timely and precise qualitative detection of EBV early antigen IgA antibodies in clinical laboratories. By combining robust reagent performance with advanced CLIA technology, this kit significantly improves diagnostic accuracy in detecting acute or reactivated EBV infections.
Comprehensive Kit ComponentsEach kit contains ready-to-use reagent vials, calibrators, controls, buffer solutions, and user-friendly instructions, enabling reliable results and straightforward implementation. The inclusion of internal calibrators and quality controls enhances result consistency and traceability, while the integrated barcode system supports efficient reagent management.
Automated and High ThroughputThe kit is designed for automated use on Snibe MAGLUMI analyzers, supporting both batch and random access testing. High throughput capability makes it suitable for busy diagnostic settings requiring rapid turnaround and high accuracy. Its portability and compact packaging ease integration into diverse laboratory environments.
FAQ's of Snibe MAGLUMI EBV EA IgA (CLIA):
Q: How is the Snibe MAGLUMI EBV EA IgA (CLIA) kit used in a laboratory setting?
A: The kit is intended for use with Snibe MAGLUMI analyzers and is employed for detecting Epstein-Barr Virus (EBV) Early Antigen IgA antibodies in human serum or plasma. Samples are prepared and loaded onto the analyzer alongside the kit reagents, with results automatically interpreted by the system's software.
Q: What components are included in each kit and how do they contribute to the testing process?
A: Each kit provides diagnostic-grade reagent vials, calibrators, controls, a buffer solution, and detailed instructions. The included calibrators and controls ensure the test's accuracy and precision, while the barcode supports efficient reagent identification and traceability.
Q: When should this kit be considered for diagnostic testing?
A: This kit is suitable when qualitative detection of EBV EA IgA is clinically indicated-commonly in cases suspected of recent or reactivated EBV infection. Ideal for use in routine and specialized diagnostic laboratories handling high volumes or batch testing.
Q: Where can the kit be stored, and what are the recommended conditions?
A: The kit should be stored at 2-8C, protected from light, to preserve reagent stability and ensure a 12-month shelf life from manufacturing. Proper storage is essential for optimal test performance.
Q: What is the process for interpreting results with this kit?
A: Results are interpreted directly via the MAGLUMI analyzer system software, following the test run. The software provides qualitative results based on the chemiluminescent signals, ensuring accuracy through internal calibrators and controls.
Q: Which benefits does the kit provide over standard EBV antibody detection methods?
A: The kit offers high sensitivity and specificity, minimal manual handling, automated processing, and consistent results with robust quality control. This reduces error rates and turnaround times compared to manual or less automated approaches.
Q: Who can supply the Snibe MAGLUMI EBV EA IgA (CLIA) kit in India?
A: Authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India offer the kit, ensuring reliable access for clinical laboratories nationwide.